Evidence map›Paper›PMID 38713301›Full record

ArticleInfectious diseases and therapy2024

Penetration Profile of Terbinafine Compared to Amorolfine in Mycotic Human Toenails Quantified by Matrix-Assisted Laser Desorption Ionization-Fourier Transform Ion Cyclotron Resonance Imaging.

Nicolas Joly-Tonetti, Raphael Legouffe, Aurore Tomezyk, Clémence Gumez, Mathieu Gaudin, David Bonnel, Martin Schaller

Abstract read
In one paragraph

Article in Infectious diseases and therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nicolas Joly-TonettiGalderma SA, Avenue d'Ouchy 4, 1006, Lausanne, Switzerland. nicolas.joly-tonetti@galderma.com.ORCID http://orcid.org/0009-0008-8491-6978
Raphael LegouffeAliri, Parc Eurasanté, 152 Rue du Dr Yersin, 59120, Loos, France.ORCID http://orcid.org/0000-0002-2421-1385
Aurore TomezykAliri, Parc Eurasanté, 152 Rue du Dr Yersin, 59120, Loos, France.
Clémence GumezAliri, Parc Eurasanté, 152 Rue du Dr Yersin, 59120, Loos, France.
Mathieu GaudinAliri, Parc Eurasanté, 152 Rue du Dr Yersin, 59120, Loos, France.ORCID http://orcid.org/0009-0002-1607-0313
David BonnelAliri, Parc Eurasanté, 152 Rue du Dr Yersin, 59120, Loos, France.ORCID http://orcid.org/0009-0004-4159-261X
Martin SchallerDepartment of Dermatology, Liebermeisterstr. 25, 72076, Tübingen, Germany.ORCID http://orcid.org/0000-0002-7930-1919

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAmorolfine 5% lacquer is an established topical treatment for fungal infection of the nails. The success of topical therapy for onychomycosis depends on whether the permeated drug concentration in the deep nail bed is retained above the effective antifungal minimum inhibitory concentration (MIC). We compared the penetration profile of amorolfine and a new topical formula of terbinafine in human mycotic toenails using matrix-assisted laser desorption ionization mass spectrometry imaging-Fourier transform ion cyclotron resonance (MALDI-FTICR) imaging.

methodsAmorolfine 5% lacquer and terbinafine 7.8% lacquer were applied to mycotic nails (n = 17); nail sections were prepared, and MALDI-FTICR analysis was performed. Based on the MICs of amorolfine and terbinafine needed to kill 90% (MIC

resultsBoth amorolfine and terbinafine penetrated the entire thickness of the nail. The mean concentration across the entire nail section 3 h following terbinafine treatment was 1414 μg/g of tissue (equivalent to 4.9 mM) compared with 780 μg/g (2.5 mM) following amorolfine treatment (not significantly different; p = 0.878). The median multiplicity of the MIC

conclusionIn this ex vivo study, MALDI-FTICR demonstrated that, although amorolfine 5% and terbinafine 7.8% had similar distribution profiles, both penetrating from the surface to the nail bed, the concentration of amorolfine in the nail was significantly higher than that of terbinafine relative to their respective MIC

Indexed as

AmorolfineInfectionMALDI-FTICRMALDI-MSINailsOnychomycosisTerbinafineTrichophyton rubrum

Identifiers

PMID38713301
PMCPMC11128419

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.